It is worth mentioning that the altered function of methylating enzymes like DOT1L or NSD2 in BCP-ALL does not lie on an altered protein expression, rather than in a differential binding affinity with their partners, as a result of genomic rearrangements that give birth to aberrant fusion proteins like KMT2A-AF4. The gene discussed is NSD2; the disease is acute lymphoblastic leukemia.